Use of ester derivatives of pyrazole proton-ionizable compounds and the corresponding salts thereof for the treatment of Chagas disease and leishmaniasis

Abstract

[EN] The invention relates to the use of ester derivatives of pyrazole, preferably proton-ionizable derivatives in neutral form or in the form of salts (pyrazolates), as drugs and, more particularly, for preventing and/or for treating diseases of parasitic origin such as Chagas disease or leishmaniasis.

[ES] Uso de ésteres derivados de pirazol, preferiblemente derivados protón-ionizables en forma neutra o en forma de sales (pirazolatos), como medicamentos y más particularmente para la prevención y/o el tratamiento de enfermedades de origen parasitario tales como la enfermedad de Chagas o la leishmaniasis.